Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
1.810
-0.020 (-1.09%)
Sep 9, 2024, 4:00 PM EDT - Market closed
Aadi Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aadi Bioscience stock has a target of 1.75, which predicts a decrease of -3.31% from the current stock price of 1.81.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for AADI stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $1.75 | Buy → Hold | Downgrades | $5 → $1.75 | -3.31% | Aug 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 21, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $5 | Buy | Maintains | $30 → $5 | +176.24% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
25.48M
from 24.35M
Increased by 4.61%
Revenue Next Year
28.56M
from 25.48M
Increased by 12.11%
EPS This Year
-2.06
from -2.44
EPS Next Year
-1.15
from -2.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.8M | 31.2M | 69.3M | ||
| Avg | 25.5M | 28.6M | 41.5M | ||
| Low | 23.8M | 26.0M | 23.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.0% | 22.5% | 142.6% | ||
| Avg | 4.6% | 12.1% | 45.2% | ||
| Low | -2.3% | 1.9% | -17.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.76 | -0.20 | -0.35 | ||
| Avg | -2.06 | -1.15 | -0.91 | ||
| Low | -2.35 | -2.35 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.